Original: Recently , targeted therapies including torisel , nexavar , sutent , and bevacizumab have been developed , and all are now approved for the treatment of metastatic renal cell carcinoma .
Simplified: Other treatments used include Nexavar , Torisel , Sutent , Interferon , and Bevacizumab .